Vaccine News and Research

Latest Vaccine News and Research

Comparative effectiveness of ChAdOx1 and BNT162b2 COVID-19 vaccines

In a recent study, researchers compared the efficacy of the Pfizer-BioNTech and Oxford-AstraZeneca COVID-19 vaccines against infection SARS-CoV-2.

21 Oct 2021

U.S. life expectancy may drop for the second year, minorities most affected

Scientists estimate the effect of the pandemic on life expectancy at birth, at 65 years overall, as well as for individual populations.

21 Oct 2021

Duke awarded NIAID funding to develop the next generation of pan-coronavirus vaccines

The National Institute of Allergy and Infectious Diseases has awarded $17.5 million over three years to the Duke Human Vaccine Institute to develop a vaccine that protects against multiple types of coronaviruses and viral variants.

21 Oct 2021

Booster dose of COVID-19 vaccine significantly increases neutralizing antibodies in rhesus macaques

A booster dose of the mRNA-1273 COVID-19 vaccine given to rhesus macaques about six months after their primary vaccine series significantly increased levels of neutralizing antibodies against all known SARS-CoV-2 variants of concern, according to a new study from National Institutes of Health scientists and colleagues.

21 Oct 2021

KHN’s ‘What the Health?’: Dems agree to agree, but not on what to agree on

Meanwhile, Biden administration officials unveil plans to provide covid-19 vaccines to younger children without looking like they are prejudging the science, in an attempt to avoid the mixed messaging that presaged the rollout of booster doses for adults.

21 Oct 2021

Study: Covid-19 vaccine is over 90% effective at preventing deaths from Delta

Vaccination is over 90 per cent effective at preventing deaths from the Delta variant of Covid-19, according to the first country-level data on mortality.

21 Oct 2021

Development of a plant-based platform for the production of SARS-CoV-2 antigen

Scientists have recently focused on the development of plant-based recombinant protein platforms.

21 Oct 2021

Immune responses to SARS-CoV-2 infection and vaccination in patients with multiple sclerosis

A new study has focused on the immune response in pwMS undergoing anti-CD20 treatment.

21 Oct 2021

Innovative method greatly simplifies the complexity of delivering vaccines

Future vaccine delivery may rely on everyday items like BBQ lighters and microneedles, thanks to the ingenuity of a team of Georgia Institute of Technology and Emory University researchers.

21 Oct 2021

Oxford vaccine trial participants believe the COVID-19 vaccine must be a shared global good

National pride in the Oxford-AstraZeneca vaccine does not outweigh desire for global greater good, suggests study with trial participants.

21 Oct 2021

Broadly protective vaccines against coronaviruses needed to protect against future outbreaks

The coronavirus disease 2019 (COVID-19) pandemic, caused by the β-coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), alerted the world to the seriousness of the threat posed by novel viruses.

20 Oct 2021

How the public views COVID-19 vaccines via Twitter in the United States

A new study uses Twitter to examine public attitudes towards the vaccines developed to fight the COVID-19 in the United States.

20 Oct 2021

Two doses of Pfizer-BioNTech vaccine effective in preventing COVID-19 hospitalization among adolescents

The Centres for Disease Control and Prevention conducted a study to determine the vaccination efficacy in the adolescent population, published recently.

20 Oct 2021

COVID-19 vaccination side effects in the USA

A new study described and compared self-reported side effects of three different COVID-19 vaccines administered between March 19 and July 15, 2021, in the United States.

20 Oct 2021

Safety and oral immunogenicity of a VSV-derived mucosal vaccine against SARS-CoV-2

A team of researchers exploited the known tropism of vesicular stomatitis virus to develop an oral vaccine that expresses the immunogenic SARS-CoV-2 spike glycoprotein in the oral mucosa.

20 Oct 2021

Long-term predictions of immunity after two doses of mRNA vaccine

Researchers from York University has investigated the long-term protection of two mRNA vaccines.

20 Oct 2021

BNT162b2 mRNA COVID-19 vaccine-induced antibodies wane over six month period

Researchers have been investigating the response of antibodies created against SARS-CoV-2 by the Pfizer-BioNTech six months after vaccination.

20 Oct 2021

Study: Marketing strategies can aid in overcoming COVID-19 vaccine hesitancy

"We are all in this together" became a rallying cry during the COVID-19 pandemic in the United States, although a significant portion of the population is not "all in" when it comes to getting vaccinated.

20 Oct 2021

An investigation of three SARS-CoV-2 mRNA doses in multiple sclerosis vaccine non-responders

A clinical study by a team of scientists from Norway aimed to assess the immunogenicity and safety of a third dose of COVID-19 mRNA vaccine in MS patients treated with anti-CD20 therapy or fingolimod. A preprint version of the study, which is yet to undergo peer review, is available on the medRxiv* server.

20 Oct 2021

Study examines decisive conditions for single or double dose COVID-19 vaccination strategies

In many parts of the world, the supply of COVID-19 vaccines continues to lag behind the demand. While most vaccines are designed as a two-dose regimen, some countries, like Canada, have prioritized vaccinating as many people as possible with a single dose before giving out an additional dose.

20 Oct 2021

Vaccine News and Research

Latest Vaccine News and Research

Comparative effectiveness of ChAdOx1 and BNT162b2 COVID-19 vaccines

U.S. life expectancy may drop for the second year, minorities most affected

Duke awarded NIAID funding to develop the next generation of pan-coronavirus vaccines

Booster dose of COVID-19 vaccine significantly increases neutralizing antibodies in rhesus macaques

KHN’s ‘What the Health?’: Dems agree to agree, but not on what to agree on

Study: Covid-19 vaccine is over 90% effective at preventing deaths from Delta

Development of a plant-based platform for the production of SARS-CoV-2 antigen

Immune responses to SARS-CoV-2 infection and vaccination in patients with multiple sclerosis

Innovative method greatly simplifies the complexity of delivering vaccines

Oxford vaccine trial participants believe the COVID-19 vaccine must be a shared global good

Broadly protective vaccines against coronaviruses needed to protect against future outbreaks

How the public views COVID-19 vaccines via Twitter in the United States

Two doses of Pfizer-BioNTech vaccine effective in preventing COVID-19 hospitalization among adolescents

COVID-19 vaccination side effects in the USA

Safety and oral immunogenicity of a VSV-derived mucosal vaccine against SARS-CoV-2

Long-term predictions of immunity after two doses of mRNA vaccine

BNT162b2 mRNA COVID-19 vaccine-induced antibodies wane over six month period

Study: Marketing strategies can aid in overcoming COVID-19 vaccine hesitancy

An investigation of three SARS-CoV-2 mRNA doses in multiple sclerosis vaccine non-responders

Study examines decisive conditions for single or double dose COVID-19 vaccination strategies

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Newsletters you may be interested in